ALLTERA LOPINAVIR AND RITONVIR TABLETS

Get a Price/Quote

MOQ : 1 Bottle

ALLTERA LOPINAVIR AND RITONVIR TABLETS Specification

Salt Composition
Lopinavir 200 mg + Ritonavir 50 mg per tablet

Origin of Medicine
Alltera brand, manufactured in India

Pacakaging (Quantity Per Box)
120 tablets per box

Indication
Treatment of HIV-1 infection

Dosage Form
Tablet

Drug Type
Allopathic

Ingredients
Lopinavir, Ritonavir

Physical Form
Tablets

Function
Antiretroviral agent for management of HIV-1 infection

Recommended For
HIV-1 infected patients as part of antiretroviral combination therapy

Dosage
As prescribed by physician, typically twice daily

Dosage Guidelines
Take with or without food, follow doctors instructions

Suitable For
Adults and pediatric patients over specified age and weight

Quantity
1 box contains 120 tablets

Storage Instructions
Store below 30C in a dry place

ALLTERA LOPINAVIR AND RITONVIR TABLETS Trade Information

Minimum Order Quantity
1 Bottle

Packaging Details
PACK OF 120 TABLETS

Main Domestic Market
All India

About ALLTERA LOPINAVIR AND RITONVIR TABLETS

PRODUCT DETAILS

Brand Name: Alltera
Content: Lopinavir& Ritonavir
Strengths: 200 mg / 50 mg
Form: Tablet
Packing: Pack of 120 Tablet
Manufactured By: Mylan

Note :- Alltera Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug.............

Effective HIV Management

ALLTERA, a protease inhibitor combination tablet, is designed to support the suppression of HIV-1 replication in infected individuals. By combining Lopinavir and Ritonavir, it offers a comprehensive approach as part of antiretroviral combination therapy, helping to improve immune function and reduce the risk of disease progression when used as prescribed.

Convenient and Reliable Packaging

Each box of ALLTERA contains 120 tablets, provided in a durable HDPE bottle within a carton for safe storage and transportation. The recommended shelf life is 24 months, ensuring long-term accessibility for patients. Clear dosage instructions and regulatory approval add to its reliability for distributors, exporters, and healthcare providers.

FAQs of ALLTERA LOPINAVIR AND RITONVIR TABLETS:

Q: How should ALLTERA Lopinavir and Ritonavir Tablets be taken for optimal effectiveness?

A: ALLTERA tablets should be taken orally, usually twice daily, and may be administered with or without food. It is vital to follow your doctors instructions precisely in terms of dose and timing to maintain consistent drug levels and maximize treatment benefits.

Q: What benefits does ALLTERA provide for HIV-1 infected patients?

A: ALLTERA helps to reduce the viral load in the body and supports the immune system by inhibiting the replication of HIV-1, which can lead to improved health outcomes and lower risk of disease progression when used within a prescribed antiretroviral regimen.

Q: When is ALLTERA contraindicated for use?

A: ALLTERA should not be used in individuals with known hypersensitivity or allergic reactions to either Lopinavir or Ritonavir. Consult your healthcare provider if you have a history of allergies to these ingredients.

Q: What side effects might occur with ALLTERA tablets?

A: Common side effects can include nausea, diarrhea, increased cholesterol, and elevated liver enzymes. Regular monitoring by your physician is recommended. Report any severe or unexpected side effects promptly.

Q: Where should ALLTERA tablets be stored to maintain their efficacy?

A: Store ALLTERA below 30C in a dry place, away from direct sunlight and moisture. Always keep the HDPE bottle tightly closed and out of reach of children.

Q: Can ALLTERA interact with other medications?

A: Yes, ALLTERA may interact with other antiretroviral agents and medicines metabolized by CYP3A enzymes. Inform your doctor of all medicines you are taking so they can assess potential interactions and adjust treatment if necessary.

Q: Is ALLTERA suitable for pediatric patients?

A: ALLTERA may be used for pediatric patients who meet the specified age and weight criteria. The exact suitability should be evaluated and determined by a physician according to individual patient requirements.

Tell us about your requirement